1. Miscarriage Treatment–Related Morbidities and Adverse Events in Hospitals, Ambulatory Surgery Centers, and Office-Based Settings
- Author
-
Roberts, Sarah CM, Beam, Nancy, Liu, Guodong, Upadhyay, Ushma D, Leslie, Douglas L, Ba, Djibril, and Kerns, Jennifer L
- Subjects
Health Services and Systems ,Health Sciences ,Abortion ,Spontaneous ,Adult ,Ambulatory Care Facilities ,Ambulatory Surgical Procedures ,Female ,Humans ,Kaplan-Meier Estimate ,Medical Office Buildings ,Morbidity ,Pregnancy ,Retrospective Studies ,miscarriage ,patient safety ,Public Health and Health Services ,Health Policy & Services ,Health services and systems - Abstract
ObjectiveThe aim of the study was to examine whether miscarriage treatment-related morbidities and adverse events vary across facility types.MethodsA retrospective cohort study compared miscarriage treatment-related morbidities and adverse events across hospitals, ambulatory surgery centers (ASCs), and office-based settings. Data on women who had miscarriage treatment between 2011 and 2014 and were continuously enrolled in their insurance plan for at least 1 year before and at least 6 weeks after treatment were obtained from a large national private insurance claims database. The main outcome was miscarriage treatment-related morbidities and adverse events occurring within 6 weeks of miscarriage treatment. Secondary outcomes were major events and infections.ResultsA total of 97,374 miscarriage treatments met inclusion criteria. Most (75%) were provided in hospitals, 10% ASCs, and 15% office-based settings. A total of 9.3% had miscarriage treatment-related events, 1.0% major events, and 1.5% infections. In adjusted analyses, there were fewer events in ASCs (6.5%) than office-based settings (9.4%) and hospitals (9.6%), but no significant difference between office-based settings and hospitals. There were no significant differences in major events between ASCs (0.7%) and office-based settings (0.8%), but more in hospitals (1.1%) than ASCs and office-based settings. There were fewer infections in ASCs (0.9%) than office-based settings (1.2%) and more in hospitals (1.6%) than ASCs and office-based settings. In analyses stratified by miscarriage treatment type, the difference between ASCs and office-based settings was no longer significant for miscarriages treated with procedures.ConclusionsAlthough there seem to be slightly more events in hospitals than ASCs or office-based settings, findings do not support limiting miscarriage treatment to particular settings.
- Published
- 2020